ConvaTec Group PLC Non-Executive Director Changes (0288D)
28 Febbraio 2022 - 12:00PM
UK Regulatory
TIDMCTEC
RNS Number : 0288D
ConvaTec Group PLC
28 February 2022
ConvaTec Group PLC
Non-Executive Directors - Appointment and Resignation
Reading, United Kingdom - Monday 28 February 2022
ConvaTec Group PLC ("ConvaTec" or "the Company") is pleased to
announce the appointment of Sharon O'Keefe as a Non-Executive
Director of the Company with effect from 1 March 2022. Sharon will
join ConvaTec's Remuneration and Nomination committees on the same
date.
The Company also announces that Rick Anderson, Non-Executive
Director, is stepping down from the Board with effect from 3 March
2022. Rick has made a significant and valuable contribution to
ConvaTec since 2016 for which the Board is immensely grateful. Rick
is also Chairman and MD of Revival Healthcare Capital, a role which
has recently expanded, and this has led to his reluctant decision
to step down from the Board of ConvaTec.
Sharon O'Keefe
From 2011 to 2020, Sharon was President and Chief Operating
Officer of U Chicago Medicine, a US nationally ranked medical
centre with a network of physicians and speciality clinics with
10,000 employees and operating revenue in excess of $2 billion.
Sharon has over 40 years of healthcare and executive experience,
with particular focus on quality, efficiency and innovation to
create high performance healthcare organisations.
Sharon is a Non-Executive Director of Adtalem Global Education,
a $1.1 billion global educational services company and of Vocera
Communications, a $200 million healthcare technology company. She
was previously a Non-Executive Director of Aviv REIT, a healthcare
real estate investment trust that was acquired by Omega Healthcare
Investors in 2015.
Sharon has an M.S. in Nursing Administration from the Loyola
University of Chicago, and a B.S. in Nursing from the Northern
Illinois University.
John McAdam, Chairman of ConvaTec, commented:
"I am delighted to welcome Sharon to our Board. She has
extensive executive-level experience in medical centre environments
with deep insight into patient care quality, engagement and
innovation. Sharon brings to the Board very relevant international,
medical and patient-focused experience. We look forward to Sharon's
contribution to our Board discussions."
"The Board is sorry to lose Rick's valuable contribution to the
Board's discussions and his deep insight into the medical device
industry. The Board accepts that Rick is now having to devote more
of his time to his role at Revival Healthcare and we wish Rick
every success and happiness for the future."
This announcement is made in accordance with Listing Rule
9.6.11R (1). No other information is required to be disclosed in
accordance with Listing Rule 9.6.13.
Enquiries:
Analysts and Investors
Kate Postans, Vice President, Investor Relations +44(0)7826 447
807
ir@convatec.com
Media
Buchanan: Chris Lane +44(0)207 466 5000
ConvaTec Group PLC's LEI code is 213800LS272L4FIDOH92
About ConvaTec Group PLC
ConvaTec is a global medical products and technologies company
focused on therapies for the management of chronic conditions, with
leading market positions in advanced wound care, ostomy care,
continence and critical care, and infusion care. Our vision, which
encompasses our purpose, is: Pioneering trusted medical solutions
to improve the lives we touch. Our products provide a range of
clinical and economic benefits including infection prevention,
protection of at-risk skin, improved patient outcomes and reduced
total cost of care. To learn more about ConvaTec, please visit
www.convatecgroup.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAPPUBCPUPPGUR
(END) Dow Jones Newswires
February 28, 2022 06:00 ET (11:00 GMT)
Grafico Azioni Convatec (LSE:CTEC)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Convatec (LSE:CTEC)
Storico
Da Apr 2023 a Apr 2024